Physician

Brad Patrick Baltz, MD

According to 2025 Medicare claims, Brad Baltz, MD (NPI: 1164484614) practices hematology/oncology in the Little Rock-North Little Rock-Conway, AR market, with the plurality of this provider's patient population coming from Pulaski, AR. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 72205-9998. Baltz is affiliated with the CommonSpirit ACO III (ACO ID: A2645), participating under the MSSP model.

Baltz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,018 traditional Medicare patients, billed 102,342 HCPCS/CPT codes, and received $2,247,062 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 4,724 prescription claims across 585 beneficiaries totaling $6,921,693 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2022 DME data shows 87 claims. Open Payments data shows 227 records totaling $3,911. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $5,458,730 to $2,247,062. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,593,598 and ending at $6,921,693. In contrast, DME billing represents a smaller volume and declined steadily, from $10,965 to $546.